Exploratory Testing and Scripted Testing Can Answer Different Questions

Lukas
By

A predefined script helps establish a specified behavior consistently. Exploration can reveal unexpected behavior that the original sequence did not anticipate. A useful plan gives each method a clear purpose.

Give exploration a defined purpose

An exploratory activity should have a scope, objective and suitable starting conditions. For a hypothetical workflow, the objective might be to investigate how the application handles incomplete data during a multi-step approval process. The tester can vary the path while remaining focused on that concern.

Define what observations need to be retained and how issues will be reported. An activity described only as “click around and check” is difficult to review because the question, coverage and outcome are unclear. The level of recording should support the decision the team intends to make.

Use scripts where repeatability matters

A specific calculation, permission boundary or recurring regression check may benefit from a controlled script with explicit expected results. The script should still reflect meaningful risk and intended use. A large number of deterministic steps does not compensate for weak acceptance criteria.

The methods can inform each other. Exploratory work may reveal an important failure condition that becomes a repeatable regression test. A scripted failure may prompt a focused exploratory investigation into related behavior. Preserve the relationship when it explains the resulting scope.

Review the combined evidence

The final assessment should explain which questions each activity addressed and whether unresolved issues remain. Avoid interpreting an exploratory session as evidence for every requirement in a broad feature area. Likewise, avoid assuming that a passing script proves the absence of unexpected behavior outside its conditions.

Validfor’s test management capabilities describe support for both approaches. Its product catalogue places execution within linked validation records, and the platform provides the wider lifecycle context. The attractive proposition is a coherent evidence story even when different testing methods contribute to it.

The final record should explain what each method established and which issues it exposed. Combining approaches is useful when their contributions remain clear and reviewable.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article